These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25339152)

  • 1. Diacylglycerol kinase α promotes 3D cancer cell growth and limits drug sensitivity through functional interaction with Src.
    Torres-Ayuso P; Daza-Martín M; Martín-Pérez J; Ávila-Flores A; Mérida I
    Oncotarget; 2014 Oct; 5(20):9710-26. PubMed ID: 25339152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diacylglycerol kinase alpha activity promotes survival of CD4+ 8+ double positive cells during thymocyte development.
    Outram SV; Crompton T; Merida I; Varas A; Martinez-A C
    Immunology; 2002 Apr; 105(4):391-8. PubMed ID: 11985659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Pathways: Targeting Diacylglycerol Kinase Alpha in Cancer.
    Purow B
    Clin Cancer Res; 2015 Nov; 21(22):5008-12. PubMed ID: 26420856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Not expecting the unexpected: diacylglycerol kinase alpha as a cancer target.
    Bhat KP; Aldape K
    Cancer Discov; 2013 Jul; 3(7):726-7. PubMed ID: 23847350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acids inhibit growth-factor-induced diacylglycerol kinase alpha activation in vascular smooth-muscle cells.
    Du X; Jiang Y; Qian W; Lu X; Walsh JP
    Biochem J; 2001 Jul; 357(Pt 1):275-82. PubMed ID: 11415460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program.
    Arranz-Nicolás J; Martin-Salgado M; Adán-Barrientos I; Liébana R; Del Carmen Moreno-Ortíz M; Leitner J; Steinberger P; Ávila-Flores A; Merida I
    Cancer Immunol Immunother; 2021 Nov; 70(11):3277-3289. PubMed ID: 33837851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual activities of ritanserin and R59022 as DGKα inhibitors and serotonin receptor antagonists.
    Boroda S; Niccum M; Raje V; Purow BW; Harris TE
    Biochem Pharmacol; 2017 Jan; 123():29-39. PubMed ID: 27974147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diacylglycerol kinase-alpha mediates hepatocyte growth factor-induced epithelial cell scatter by regulating Rac activation and membrane ruffling.
    Chianale F; Cutrupi S; Rainero E; Baldanzi G; Porporato PE; Traini S; Filigheddu N; Gnocchi VF; Santoro MM; Parolini O; van Blitterswijk WJ; Sinigaglia F; Graziani A
    Mol Biol Cell; 2007 Dec; 18(12):4859-71. PubMed ID: 17898083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylinositol Phosphate 5-Kinase Iγ and Phosphoinositide 3-Kinase/Akt Signaling Couple to Promote Oncogenic Growth.
    Thapa N; Choi S; Tan X; Wise T; Anderson RA
    J Biol Chem; 2015 Jul; 290(30):18843-54. PubMed ID: 26070568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diacylglycerol kinase inhibition prevents IL-2-induced G1 to S transition through a phosphatidylinositol-3 kinase-independent mechanism.
    Flores I; Jones DR; Ciprés A; Díaz-Flores E; Sanjuan MA; Mérida I
    J Immunol; 1999 Jul; 163(2):708-14. PubMed ID: 10395661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Abl tyrosine kinase regulates serum-induced nuclear export of diacylglycerol kinase α by phosphorylation at Tyr-218.
    Matsubara T; Ikeda M; Kiso Y; Sakuma M; Yoshino K; Sakane F; Merida I; Saito N; Shirai Y
    J Biol Chem; 2012 Feb; 287(8):5507-17. PubMed ID: 22199356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diacylglycerol kinases in cancer.
    Mérida I; Torres-Ayuso P; Ávila-Flores A; Arranz-Nicolás J; Andrada E; Tello-Lafoz M; Liébana R; Arcos R
    Adv Biol Regul; 2017 Jan; 63():22-31. PubMed ID: 27697466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of ritanserin analogs that display DGK isoform specificity.
    Granade ME; Manigat LC; Lemke MC; Purow BW; Harris TE
    Biochem Pharmacol; 2022 Mar; 197():114908. PubMed ID: 34999054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers.
    Dominguez CL; Floyd DH; Xiao A; Mullins GR; Kefas BA; Xin W; Yacur MN; Abounader R; Lee JK; Wilson GM; Harris TE; Purow BW
    Cancer Discov; 2013 Jul; 3(7):782-97. PubMed ID: 23558954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predominant contribution of DGKζ over DGKα in the control of PKC/PDK-1-regulated functions in T cells.
    Ávila-Flores A; Arranz-Nicolás J; Andrada E; Soutar D; Mérida I
    Immunol Cell Biol; 2017 Jul; 95(6):549-563. PubMed ID: 28163304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models.
    Formisano L; Nappi L; Rosa R; Marciano R; D'Amato C; D'Amato V; Damiano V; Raimondo L; Iommelli F; Scorziello A; Troncone G; Veneziani B; Parsons SJ; De Placido S; Bianco R
    Breast Cancer Res; 2014 May; 16(3):R45. PubMed ID: 24887236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression of type I diacylglycerol kinases in pancreatic β-cells from male mice results in impaired insulin secretion.
    Kurohane Kaneko Y; Kobayashi Y; Motoki K; Nakata K; Miyagawa S; Yamamoto M; Hayashi D; Shirai Y; Sakane F; Ishikawa T
    Endocrinology; 2013 Nov; 154(11):4089-98. PubMed ID: 24035999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diacylglycerol kinase α-selective inhibitors induce apoptosis and reduce viability of melanoma and several other cancer cell lines.
    Yamaki A; Akiyama R; Murakami C; Takao S; Murakami Y; Mizuno S; Takahashi D; Kado S; Taketomi A; Shirai Y; Goto K; Sakane F
    J Cell Biochem; 2019 Jun; 120(6):10043-10056. PubMed ID: 30536880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectivity of the diacylglycerol kinase inhibitor 3-[2-(4-[bis-(4-fluorophenyl)methylene]-1-piperidinyl)ethyl]-2, 3-dihydro-2-thioxo-4(1H)quinazolinone (R59949) among diacylglycerol kinase subtypes.
    Jiang Y; Sakane F; Kanoh H; Walsh JP
    Biochem Pharmacol; 2000 Apr; 59(7):763-72. PubMed ID: 10718334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diacylglycerol kinase α exacerbates cardiac injury after ischemia/reperfusion.
    Sasaki T; Shishido T; Kadowaki S; Kitahara T; Suzuki S; Katoh S; Funayama A; Netsu S; Watanabe T; Goto K; Takeishi Y; Kubota I
    Heart Vessels; 2014 Jan; 29(1):110-8. PubMed ID: 23719772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.